health
We finally got Alzheimer’s breakthroughs. Why is Washington holding them back?
Alzheimer’s disease is no longer a distant threat affecting only a small segment of the population. It is a growing national crisis that touches nearly every American family in some way.
TL;DR
- Alzheimer's affects an estimated 7.4 million Americans aged 65+, with numbers projected to nearly double by 2060.
- The disease has no cure and is a leading cause of death, impacting families through unpaid caregiving which incurs significant financial and emotional costs.
- Projected healthcare and long-term care costs for Alzheimer's and other dementias will reach $409 billion in 2026, excluding unpaid caregiving valued at over $446 billion in 2025.
- FDA-approved therapies can slow cognitive decline in early stages, and a new blood test aids in diagnosis, offering less invasive options.
- Early diagnosis allows for sooner treatment, clinical trial participation, and better personal decision-making, preserving independence.
- Barriers to diagnosis, treatment, and specialized care persist due to a shortage of specialists, varying insurance policies, and restrictive Medicare coverage.
- A coordinated national Alzheimer's initiative is advocated to improve health outcomes, strengthen families, reduce healthcare spending, and boost economic productivity.
- Key components of the initiative include increased federal research investment, prioritizing brain health and risk reduction, improving diagnostic access, and ensuring equitable treatment access.
- Texas has established a Dementia Prevention and Research Institute and funded it with $3 billion, signaling a commitment to addressing dementia.
- The article calls for Washington to follow Texas's example with a similar urgent and coordinated response to Alzheimer's.